跳至主要内容
临床试验/ACTRN12616000404426
ACTRN12616000404426已完成4 期

A new technique to reduce possible systemic side effects of eye drops: the difference in plasma concentration of Timolol after dry tissue pressure compared to nasolacrimal occlusion following ocular application

uzia Mueller0 个研究点目标入组 20 人开始时间: 2016年3月30日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants must be 18 years old or more and be able to understand the purpose of this study and perform the interventions following Timolol application. Otherwise, all people, not fulfilling any of the exclusion criteria may be included. Informed consent has to be obtained.

排除标准

  • -Health conditions that increase the probability of side effects of Timolol
  • -Hypersensitivity to Timolol or one of the additives
  • -Systemic Beta blocker intake
  • -Inability to understand and perform the instructions
  • -Pregnancy or ongoing breast feeding

研究者

发起方
uzia Mueller

相似试验